SUBSTIPHARM
Pharmaceutical products, worldwide supplier
- B2B
- Manufacturing
- Sales-led purchase
About SUBSTIPHARM
Develops, supplies, and commercializes pharmaceuticals globally, including mature brands, generics, OTC, difficult medicines, and biological products.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 1995
- Revenue
- $19.8M – $156MTamtam estimate
- SIREN
- 480064385
- Website
- substipharm.com
SUBSTIPHARM in the news
- MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market
Medigen Vaccine Biologics Corp. and Substipharm Biologics secured marketing authorization for the first Enterovirus A71 vaccine in Vietnam to combat pediatric HFMD outbreaks.
- DHL Supply Chain signe un partenariat avec Substipharm, groupe biopharmaceutique spécialisé dans le développement et la commercialisation de médicaments et vaccins
DHL Supply Chain is partnering with Substipharm to manage the logistics and distribution of Aspégic and Kardégic brands across France.
- DHL Supply Chain déploie un dispositif pharma pour Substipharm
DHL Supply Chain is managing the full logistics cycle for Substipharm's newly acquired Aspégic and Kardégic medicine brands in France.
- Envacgen becomes Vietnam's first EV-A71 vaccine, paving way for Southeast Asia expansion
Substipharm Biologics and MVC have secured Vietnamese approval for Envacgen, the first EV-A71 vaccine to combat hand, foot, and mouth disease in the region.
- MVC's Envacgen granted the first enterovirus A71 vaccine marketing authorization in Vietnam
Medigen and Substipharm have secured Vietnam's first marketing authorization for an EV-A71 vaccine to combat local pediatric HFMD outbreaks.
SUBSTIPHARM at a glance
SUBSTIPHARM is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Paris, Île-de-France, France.
SUBSTIPHARM was founded in 1995.
SUBSTIPHARM has 51–250 employees.
SUBSTIPHARM's revenue is $19.8M – $156M (Tamtam estimate).
SUBSTIPHARM's SIREN number is 480064385.
Selling to companies like SUBSTIPHARM?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies